EDGAR Filing Documents for 9999999995-23-001320

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-23-001320

Accepted

2023-05-08 00:15:33

Documents

Effectiveness Date

2023-05-05

Registration Form

S-3

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	595
	Complete submission text file	9999999995-23-001320.txt		1709

Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169

Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841

Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)